Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
EV/EBITDA | ? | -2.00 | -11.1 | -0.09 | 0.31 | -0.20 | -0.03 | |
Changes by years, y/y, % | -134% | +456% | -99% | -435% | -166% |
Black Diamond Therapeutics. EV/EBITDA
Black Diamond Therapeutics. EV/EBITDA, changes, %
Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EV/EBITDA | ? | 0.08 | -1.39 | -0.31 | -0.45 | -2.03 | -0.03 | |
Changes by years, y/y, % | -101% | -48% | -83% | -247% | -2 742% | |||
Changes by quarters, q/q, % | -75% | -1 910% | -78% | +45% | +348% |